{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:48:09Z","timestamp":1794329289500,"version":"4.9.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Center for Scientific Information","doi-asserted-by":"publisher","award":["19\\u201333\\u201370048"],"award-info":[{"award-number":["19\\u201333\\u201370048"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","award":["22\\u201315\\u201300098"],"award-info":[{"award-number":["22\\u201315\\u201300098"]}],"id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.nucmedbio.2024.108991","type":"journal-article","created":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T02:54:50Z","timestamp":1736045690000},"page":"108991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci"],"prefix":"10.1016","volume":"142-143","author":[{"given":"Kristina A.","family":"Petrosova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr S.","family":"Lunev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marat G.","family":"Rakhimov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksey E.","family":"Machulkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia S.","family":"Volkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fedor I.","family":"Vasilevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton A.","family":"Larenkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.nucmedbio.2024.108991_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02985584","article-title":"Targeted molecular imaging in oncology","volume":"20","author":"Yang","year":"2006","journal-title":"Ann Nucl Med"},{"issue":"5","key":"10.1016\/j.nucmedbio.2024.108991_bb0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1089\/dna.2005.24.271","article-title":"Receptor-targeted cancer therapy","volume":"24","author":"Richter","year":"2005","journal-title":"DNA Cell Biol"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0015","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.3390\/molecules25112712","article-title":"Pharmacokinetic properties of 68Ga-labelled folic acid conjugates: improvement using HEHE tag","volume":"25","author":"Larenkov","year":"2020","journal-title":"Molecules"},{"issue":"7463","key":"10.1016\/j.nucmedbio.2024.108991_bb0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nature12327","article-title":"Structural basis for molecular recognition of folic acid by folate receptors","volume":"500","author":"Chen","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.nucmedbio.2024.108991_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.14341\/omet201639-14","article-title":"Possible biochemical mechanisms involved in beneficial and adverse effects of folates","volume":"13","author":"Shaljyan","year":"2016","journal-title":"Obes Metab"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0030","doi-asserted-by":"crossref","unstructured":"Necela BM. Crozier JA. Andorfer CA. Lewis-Tuffin L. Kachergus JM. Geiger XJ. Kalari KR. Serie DJ. Sun Z. Aspita AM. O'Shannessy DJ. Maltzman JD. McCullough AE. Pockaj BA. Cunliffe HE. Ballman KV. Thompson EA. Perez1 EA. Folate Receptor-\u03b1 (FOLR1) Expression and Function in Triple Negative Tumors. PLoS ONE 2015;10(3):e0122209. DOI:https:\/\/doi.org\/10.1371\/journal.pone.0122209.","DOI":"10.1371\/journal.pone.0122209"},{"issue":"8","key":"10.1016\/j.nucmedbio.2024.108991_bb0035","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2174\/138161212799315777","article-title":"Folate based radiopharmaceuticals for imaging and therapy of Cancer and inflammation","volume":"18","author":"M\u00fcller","year":"2012","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0040","first-page":"700","article-title":"Evaluation of 111In-DTPA- folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results","volume":"44","author":"Siegel","year":"2003","journal-title":"J Nucl Med"},{"issue":"44","key":"10.1016\/j.nucmedbio.2024.108991_bb0045","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1038\/sj.onc.1203839","article-title":"Downmodulation of caveolin-1 expression in human ovarian carcinoma is directly related to alpha-folate receptor overexpression","volume":"19","author":"Bagnoli","year":"2000","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.nucmedbio.2024.108991_bb0050","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.21712","article-title":"The role of folate receptor alpha in cancer development. Progression and treatment: cause. Consequence or innocent bystander?","volume":"119","author":"Kelemen","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0055","doi-asserted-by":"crossref","unstructured":"Siu MK. Kong DS. Chan HY. Wong ES. Ip PP. Jiang L. Ngan HYS. Le X-F. Cheung ANY. Paradoxical impact of two folate receptors. FR\u03b1 and RFC. In ovarian cancer: effect on cell proliferation. Invasion and clinical outcome. PLoS One 2012;7(11) DOI:https:\/\/doi.org\/10.1371\/journal.pone.0047201.","DOI":"10.1371\/journal.pone.0047201"},{"issue":"23","key":"10.1016\/j.nucmedbio.2024.108991_bb0060","first-page":"6708","article-title":"Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis","volume":"52","author":"Weitman","year":"1992","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.nucmedbio.2024.108991_bb0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F","article-title":"Overexpression of folate binding protein in ovarian cancers","volume":"74","author":"Toffoli","year":"1997","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.nucmedbio.2024.108991_bb0070","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","article-title":"Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay","volume":"338","author":"Parker","year":"2005","journal-title":"Anal Biochem"},{"issue":"9","key":"10.1016\/j.nucmedbio.2024.108991_bb0075","first-page":"2432","article-title":"Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines","volume":"73","author":"Ross","year":"1994","journal-title":"Physiologic and clinical implications Cancer"},{"issue":"14","key":"10.1016\/j.nucmedbio.2024.108991_bb0080","first-page":"4218","article-title":"Differential expression of folate receptor in pituitary adenomas","volume":"63","author":"Evans","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2310\/7290.2013.00074","article-title":"Imaging atherosclerotic plaque inflammation via folate receptor targeting using a novel 18F-folate radiotracer","volume":"13","author":"M\u00fcller","year":"2014","journal-title":"Mol Imaging"},{"issue":"4","key":"10.1016\/j.nucmedbio.2024.108991_bb0090","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1039\/C7SC04004K","article-title":"Advances in targeting the folate receptor in the treatment\/imaging of cancers","volume":"9","author":"Fernandez","year":"2018","journal-title":"Chem Sci"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0095","doi-asserted-by":"crossref","unstructured":"Xia W. Hilgenbrink AR. Matteson EL. Lockwood MB. Cheng J-X. Low PS. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 2008;113(2):438\u2013446. doi:https:\/\/doi.org\/10.1182\/blood-2008-04-150789.","DOI":"10.1182\/blood-2008-04-150789"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0100","doi-asserted-by":"crossref","unstructured":"Puig-Kroger A. Sierra-Filardi E. Dominguez-Soto A. Samaniego R. Corcuera MT. Gomez-Aguado F. Ratnam M. Sanchez-Mateos P. Corbi A.L. Folate receptor is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory\/regulatory macrophages. Cancer Res 2009;69(24):9395\u20139403. doi:https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-2050.","DOI":"10.1158\/0008-5472.CAN-09-2050"},{"issue":"8","key":"10.1016\/j.nucmedbio.2024.108991_bb0105","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.addr.2004.01.012","article-title":"Folate receptor-mediated targeting of therapeutic and imaging agents to activated macrophages in rheumatoid arthritis","volume":"56","author":"Paulos","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"issue":"7","key":"10.1016\/j.nucmedbio.2024.108991_bb0110","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1245\/s10434-012-2263-0","article-title":"Clinical significance of folate receptor \u03b2-expressing tumor-associated macrophages in pancreatic cancer","volume":"19","author":"Kurahara","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.nucmedbio.2024.108991_bb0115","doi-asserted-by":"crossref","first-page":"E312","DOI":"10.1002\/lary.24606","article-title":"In vivo optical imaging of folate receptor-\u03b2 in head and neck squamous cell carcinoma","volume":"124","author":"Sun","year":"2014","journal-title":"Laryngoscope"},{"issue":"16","key":"10.1016\/j.nucmedbio.2024.108991_bb0120","doi-asserted-by":"crossref","first-page":"14700","DOI":"10.18632\/oncotarget.3739","article-title":"Assessment of folate receptor-\u03b2 expression in human neoplastic tissues","volume":"6","author":"Shen","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.nucmedbio.2024.108991_bb0125","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/ar3312","article-title":"A folate receptor beta-specific human monoclonal antibody recognizes activated macrophage of rheumatoid patients and mediates antibody-dependent cell-mediated cytotoxicity","volume":"13","author":"Feng","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0130","doi-asserted-by":"crossref","unstructured":"Samaniego R. Dominguez-Soto A. Ratnam M. Matsuyama T. Sanchez-Mateos P. Corbi A.L. Puig-Kroger A. Folate receptor \u03b2 (FR\u03b2) expression in tissue-resident and tumor-associated macrophages associates with and depends on the expression of PU.1. Cells 2020;9(6):1445. doi:https:\/\/doi.org\/10.3390\/cells9061445.","DOI":"10.3390\/cells9061445"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0135","first-page":"12","author":"Treatment and diagnosis of macrophage-mediated diseases. Patent RU 2 480 241 C2","year":"2013","journal-title":"Bull"},{"issue":"38","key":"10.1016\/j.nucmedbio.2024.108991_bb0140","doi-asserted-by":"crossref","first-page":"15180","DOI":"10.1073\/pnas.1308827110","article-title":"Structures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognition","volume":"110","author":"Wibowoa","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0145","first-page":"8","author":"A method for creating a biological model of systemic juvenile idiopathic arthritis in an experiment. Patent RU 2 612 843 C","year":"2017","journal-title":"Bull"},{"issue":"7","key":"10.1016\/j.nucmedbio.2024.108991_bb0150","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1002\/art.10405","article-title":"Folate-targeted imaging of activated macrophages in rats with adjuvant-induced arthritis","volume":"46","author":"Turk","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.nucmedbio.2024.108991_bb0155","first-page":"253","article-title":"Assessment of disease activity in rheumatoid arthritis using a novel folate tar got radiopharmaceutical folate scan","volume":"27","author":"Matteson","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0160","doi-asserted-by":"crossref","unstructured":"Vegt E; Eek A; Oyen WJG. de Jong M. Gotthardt M. Boerman OC. Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides. Eur J Nucl Med Mol Imaging 2010;37(2):226\u2013234. doi:https:\/\/doi.org\/10.1007\/s00259-009-1239-1.","DOI":"10.1007\/s00259-009-1239-1"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0165","doi-asserted-by":"crossref","unstructured":"de Visser HM. Korthagen NM. Muller C. Ramakers RM. Krijger GC. Lafeber FPJG. Beekman FJ. Mastbergen SC. Weinans H. Imaging of folate receptor expressing macrophages in the rat groove model of osteoarthritis: using a new DO-TA-folate conjugate. Cartilage 2018;9(2):183\u2013191. doi:https:\/\/doi.org\/10.1177\/19476035177380.","DOI":"10.1177\/1947603517738073"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0170","series-title":"State Standart 33044\u20132014. Good laboratory practice","year":"2019"},{"key":"10.1016\/j.nucmedbio.2024.108991_bb0175","series-title":"European convention for the protection of vertebrate animals used for experimental and other scientific purposes","first-page":"123","author":"Council of Europe","year":"1986"},{"issue":"1","key":"10.1016\/j.nucmedbio.2024.108991_bb0180","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10967-015-4089-2","article-title":"Preparation of highly purified 68Ga solutions via ion exchange in hydrochloric acid\u2013ethanol mixtures","volume":"305","author":"Larenkov","year":"2015","journal-title":"J Radioanal Nucl Chem"},{"issue":"1","key":"10.1016\/j.nucmedbio.2024.108991_bb0185","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/43.1.95","article-title":"Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy. Safety and non-compartmental pharmacokinetics","volume":"43","author":"Groll","year":"1999","journal-title":"J Antimicrob Chemother"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124001173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124001173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:03:52Z","timestamp":1746101032000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124001173"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":37,"alternative-id":["S0969805124001173"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108991","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical evaluation of 68Ga-labeled folic acid conjugates for visualization of inflammatory foci","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108991","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108991"}}